Utah Retirement Systems Charles River Laboratories International, Inc. Transaction History

Utah Retirement Systems

$8.31 Billion
Q2 2024

A detailed history of Utah Retirement Systems transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Utah Retirement Systems holds 8,395 shares of CRL stock, worth $1.67 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

8,395

Previous 8,795 4.55%

Holding current value

$1.67 Million

Previous $2.38 Million 27.23%

% of portfolio

0.02%

Previous 0.03%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$206.39 - $268.73 $82,556 - $107,492	-400 Reduced 4.55%	8,395 $1.73 Million
Q4 2023 Feb 14, 2024	BUY	$164.52 - $238.84 $16,452 - $23,884	100 Added 1.15%	8,795 $2.08 Million
Q2 2023 Aug 14, 2023	SELL	$183.71 - $210.25 $55,113 - $63,075	-300 Reduced 3.34%	8,695 $1.83 Million
Q4 2022 Feb 15, 2023	SELL	$197.11 - $250.07 $19,711 - $25,007	-100 Reduced 1.1%	8,995 $1.96 Million
Q3 2022 Nov 14, 2022	BUY	$182.44 - $250.54 $36,488 - $50,108	200 Added 2.25%	9,095 $1.79 Million
Q1 2022 May 13, 2022	SELL	$255.51 - $362.11 $25,551 - $36,211	-100 Reduced 1.11%	8,895 $2.53 Million
Q4 2021 Feb 14, 2022	BUY	$351.38 - $448.68 $15,109 - $19,293	43 Added 0.48%	8,995 $3.39 Million
Q3 2021 Nov 16, 2021	SELL	$372.64 - $458.3 $186,320 - $229,150	-500 Reduced 5.29%	8,952 $3.69 Million
Q2 2021 Aug 16, 2021	BUY	$294.17 - $371.65 $10,884 - $13,751	37 Added 0.39%	9,452 $3.5 Million
Q1 2021 May 17, 2021	SELL	$249.67 - $299.48 $90,879 - $109,010	-364 Reduced 3.72%	9,415 $2.73 Million
Q4 2020 Feb 16, 2021	BUY	$222.0 - $252.62 $88,800 - $101,048	400 Added 4.26%	9,779 $2.44 Million
Q3 2020 Nov 16, 2020	BUY	$175.56 - $226.45 $17,556 - $22,645	100 Added 1.08%	9,379 $2.12 Million
Q2 2020 Aug 13, 2020	BUY	$118.84 - $189.72 $11,884 - $18,972	100 Added 1.09%	9,279 $1.62 Million
Q4 2019 Feb 12, 2020	BUY	$126.05 - $152.76 $12,605 - $15,276	100 Added 1.1%	9,179 $1.4 Million
Q2 2019 Aug 14, 2019	BUY	$123.4 - $148.55 $20,978 - $25,253	170 Added 1.91%	9,079 $1.29 Million
Q1 2019 May 15, 2019	BUY	$104.82 - $146.73 $11,739 - $16,433	112 Added 1.27%	8,909 $1.3 Million
Q4 2017 Feb 14, 2018	BUY	$100.43 - $118.09 $20,086 - $23,618	200 Added 2.33%	8,797 $963,000
Q3 2017 Nov 13, 2017	BUY	$96.72 - $109.26 $831,501 - $939,308	8,597	8,597 $928,000

Others Institutions Holding CRL

# of Institutions

732

Shares Held

51.8M

Call Options Held

233K

Put Options Held

236K

View Full List

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $10.1B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

More about CRL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Utah Retirement Systems, based on Form 13F filings with the SEC.

News

Stay updated on Utah Retirement Systems with notifications on news.

Account

Utah Retirement Systems Charles River Laboratories International, Inc. Transaction History